Atrophy, metaplasia and dysplasia

Are they reversible?

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

The eradication of Helicobacter pylori results in the decrease and eventual disappearance of inflammation in the gastric mucosa. An important question with practical implications is whether treatment of H. pylori can promote the resolution of atrophy and intestinal metaplasia. If this happens, then one could infer that even in the presence of established multifocal atrophic gastritis the cure of Helicobacter pylori could reduce the risk of developing gastric cancer. Several investigators have addressed the issue, but the cumulative results remain inconclusive. The great latitude that there exists in the interpretation of the concept of atrophy and the patchy distribution of both atrophic changes and intestinal metaplasia (with resulting inevitable sampling error) are important reasons for the wide discrepancy in the conclusions reached by different authors. Controlled, long-term prospective studies conducted in different ethnic and geographic settings are needed to provide sound evidence-based answers to the question of reversibility of atrophy, intestinal metaplasia, and epithelial dysplasia.

Original languageEnglish (US)
JournalItalian Journal of Gastroenterology and Hepatology
Volume30
Issue numberSUPPL. 3
StatePublished - 1998

Fingerprint

Metaplasia
Helicobacter pylori
Atrophy
Atrophic Gastritis
Selection Bias
Gastric Mucosa
Stomach Neoplasms
Research Personnel
Prospective Studies
Inflammation

Keywords

  • Atrophy metaplasia
  • Dysplasia
  • Helicobacter pylori eradication

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Atrophy, metaplasia and dysplasia : Are they reversible? / Genta, R. M.

In: Italian Journal of Gastroenterology and Hepatology, Vol. 30, No. SUPPL. 3, 1998.

Research output: Contribution to journalArticle

@article{6a4141f701a543b3ada4c35e22e99703,
title = "Atrophy, metaplasia and dysplasia: Are they reversible?",
abstract = "The eradication of Helicobacter pylori results in the decrease and eventual disappearance of inflammation in the gastric mucosa. An important question with practical implications is whether treatment of H. pylori can promote the resolution of atrophy and intestinal metaplasia. If this happens, then one could infer that even in the presence of established multifocal atrophic gastritis the cure of Helicobacter pylori could reduce the risk of developing gastric cancer. Several investigators have addressed the issue, but the cumulative results remain inconclusive. The great latitude that there exists in the interpretation of the concept of atrophy and the patchy distribution of both atrophic changes and intestinal metaplasia (with resulting inevitable sampling error) are important reasons for the wide discrepancy in the conclusions reached by different authors. Controlled, long-term prospective studies conducted in different ethnic and geographic settings are needed to provide sound evidence-based answers to the question of reversibility of atrophy, intestinal metaplasia, and epithelial dysplasia.",
keywords = "Atrophy metaplasia, Dysplasia, Helicobacter pylori eradication",
author = "Genta, {R. M.}",
year = "1998",
language = "English (US)",
volume = "30",
journal = "Digestive and Liver Disease",
issn = "1590-8658",
publisher = "Elsevier",
number = "SUPPL. 3",

}

TY - JOUR

T1 - Atrophy, metaplasia and dysplasia

T2 - Are they reversible?

AU - Genta, R. M.

PY - 1998

Y1 - 1998

N2 - The eradication of Helicobacter pylori results in the decrease and eventual disappearance of inflammation in the gastric mucosa. An important question with practical implications is whether treatment of H. pylori can promote the resolution of atrophy and intestinal metaplasia. If this happens, then one could infer that even in the presence of established multifocal atrophic gastritis the cure of Helicobacter pylori could reduce the risk of developing gastric cancer. Several investigators have addressed the issue, but the cumulative results remain inconclusive. The great latitude that there exists in the interpretation of the concept of atrophy and the patchy distribution of both atrophic changes and intestinal metaplasia (with resulting inevitable sampling error) are important reasons for the wide discrepancy in the conclusions reached by different authors. Controlled, long-term prospective studies conducted in different ethnic and geographic settings are needed to provide sound evidence-based answers to the question of reversibility of atrophy, intestinal metaplasia, and epithelial dysplasia.

AB - The eradication of Helicobacter pylori results in the decrease and eventual disappearance of inflammation in the gastric mucosa. An important question with practical implications is whether treatment of H. pylori can promote the resolution of atrophy and intestinal metaplasia. If this happens, then one could infer that even in the presence of established multifocal atrophic gastritis the cure of Helicobacter pylori could reduce the risk of developing gastric cancer. Several investigators have addressed the issue, but the cumulative results remain inconclusive. The great latitude that there exists in the interpretation of the concept of atrophy and the patchy distribution of both atrophic changes and intestinal metaplasia (with resulting inevitable sampling error) are important reasons for the wide discrepancy in the conclusions reached by different authors. Controlled, long-term prospective studies conducted in different ethnic and geographic settings are needed to provide sound evidence-based answers to the question of reversibility of atrophy, intestinal metaplasia, and epithelial dysplasia.

KW - Atrophy metaplasia

KW - Dysplasia

KW - Helicobacter pylori eradication

UR - http://www.scopus.com/inward/record.url?scp=0031698267&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031698267&partnerID=8YFLogxK

M3 - Article

VL - 30

JO - Digestive and Liver Disease

JF - Digestive and Liver Disease

SN - 1590-8658

IS - SUPPL. 3

ER -